Font size: +
3 minutes reading time (625 words)

Addiction News & Policy Update for Week Ending October 14

Addiction News & Policy Update for Week Ending October 14

Our Weekly Addiction News & Policy Update is a compilation of news items provided to Wellspring by a variety of sources. Wellspring staff assembles this information and is pleased to provide it to you. If you have any questions, comments, or suggestions, feel free to contact us at This email address is being protected from spambots. You need JavaScript enabled to view it..

The content of this email does not represent the official views or policies of Wellspring Center for Prevention. The content has been collected from a variety of sources and is provided for informational purposes only. The appearance of external hyperlinks does not constitute endorsement by Wellspring of the linked web sites, or the information, products or services contained therein. If you do not wish to receive this email in the future, simply email us at This email address is being protected from spambots. You need JavaScript enabled to view it. and ask to be unsubscribed.

Treatment community largely absent from ballot debate on legalization

If opponents of easing legal restrictions on marijuana use succeed in seeing some of five recreational marijuana initiatives fail at the polls next month, they likely will do so despite a relatively underfinanced effort with minimal participation from treating professionals who address the adverse consequences of expanded access.
Learn More

Medications to treat alcohol abuse are often overlooked

Drugs that could help millions of people who struggle with alcohol abuse problems are often overlooked by doctors and patients, according to public health officials.
Learn More

 

Drug Makers Disagree on Overdose Antidote

Drug companies have their differences when it comes to how dosing should be administered following an opioid overdose.
Learn More

 

Alcohol Use Disorder Drug Shows Promise

An experimental drug -- a vasopressin antagonist called ABT-436 -- shows some promise in treating alcohol use disorder and smoking, according to a study published online in Neuropsychopharmacology.
Learn More

 

Novel Compound May Help Stress-Related Alcohol Abuse

The novel compound ABT-436, a V1b receptor antagonist, may be particularly useful for treating people with alcohol use disorder who also have high anxiety and stress levels, new research shows.
Learn More

 

Cartels Selling Deadly Fentanyl Disguised as Other Drug

The cartel's fentanyl is much more dangerous than pharmaceutical fentanyl
Learn More

 

Support for marijuana legalization continues to rise

The share of Americans who favor legalizing the use of marijuana continues to increase.
Learn More

 

New opioids could relieve pain without dangerous side effects

Once hailed as saviors of pain patients everywhere, opioids — including oxycodone and fentanyl — have caused an addiction epidemic in the United States and earned the scorn of doctors, patients and lawmakers
Learn More

 

How drug companies helped drive the opioid crisis

The abuse of opioids has become a major public health concern; more than 28,000 people died by overdose in 2014. According to reporting by STAT News, drug companies downplayed the addictive effects of opioid drugs in the late 1990s, assuring doctors that they could be safely used for chronic pain and incentivised their use.
Learn More

0
Medicine Take Back Day Returns to Middlesex County...
It’s All About Love and Enabling

Related Posts

 

Subscribe to Our Blogs

Archive